Mammographic fatty tissue density of breast
ICD-10 R92.31 is a billable code used to indicate a diagnosis of mammographic fatty tissue density of breast.
Mammographic fatty tissue density of the breast refers to the composition of breast tissue as seen on a mammogram, where the density of fatty tissue is assessed. This finding indicates that the breast contains a higher proportion of fatty tissue compared to glandular or fibrous tissue. Fatty tissue density is a significant factor in mammography as it can affect the visibility of lesions or abnormalities. High breast density can obscure tumors, making it more challenging to detect breast cancer. Conversely, lower density may facilitate easier detection of abnormalities. The assessment of breast density is crucial for risk stratification in breast cancer screening and may influence the frequency and type of screening recommended for patients. It is important to note that while fatty tissue density itself is not a disease, it is an important characteristic that can impact clinical decisions and patient management.
Documentation should include the patient's breast density assessment, any related symptoms, and follow-up recommendations.
Patients presenting for routine screening mammograms or those with a family history of breast cancer.
Consideration of the patient's overall risk factors for breast cancer and the implications of breast density on screening protocols.
Acute care documentation should detail the reason for the mammogram, findings, and any immediate clinical implications.
Patients presenting with breast pain or palpable masses requiring urgent evaluation.
Emergency settings may require rapid assessment and documentation of findings to guide immediate management.
Used when a diagnostic mammogram is performed due to abnormal findings.
Documentation must include the reason for the diagnostic mammogram and findings.
In breast specialty clinics, ensure that the findings correlate with the patient's risk factors.
R92.31 indicates that a mammogram has shown fatty tissue density in the breast, which is an important factor in assessing breast cancer risk.
R92.31 should not be used for patients with diagnosed breast cancer unless specifically indicating the density finding; it is primarily for screening purposes.
